Medarex, Inc.

Company Information

Company Name
Medarex, Inc.
Address
707 State Road
Princeton, NJ, 08540
Phone
1 908-479-2464
URL
n/a
DUNS
n/a
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$875,908.00
8
SBIR Phase II
$684,590.00
1
STTR Phase I
$200,000.00
3
STTR Phase II
$264,820.00
1

Award List

  1. IFN-GAMMA BIOASSAYS

    Amount: $50,000.00

    IFN- IS CURRENTLY BEING TESTED FOR THE TREATMENT OF A WIDE RANGE OF DISEASES INCLUDING AUTOIMMUNE AND INFECTIOUS DISEASES, SOLID TUMORS AND HEMATOLOGIC MALIGNANCIES. AS WITH OTHER BIOLOGICAL RESPONSE ...

    SBIR Phase I 1988 Department of Health and Human Services
  2. ELIMINATION OF ANTIGEN REACTIVE B CELLS

    Amount: $50,000.00

    MEDAREX HAS EXCLUSIVE LICENSE TO SEVERAL MONOCLONAL ANTIBODIES (MABS) REACTIVE TO THE HIGH AFFINITY FC RECEPTOR FOR IGG (FCGRI), ON HUMAN MONOCYTES. THIS RECEPTOR IS A CRITICAL TRIGGER MOLECULE FOR AD ...

    SBIR Phase I 1988 Department of Health and Human Services
  3. BI-SPECIFIC ANTIBODY-DIRECTED KILLING IN HIV THERAPY

    Amount: $50,000.00

    MEDAREX, INC., HAS EXCLUSIVE LICENSE TO SEVERAL MONOCLONAL ANTIBODIES (MABS) REACTIVE TO THE HIGH-AFFINITY FC RECEPTOR FOR IGG (FC RI), WHICH IS EXPRESSED ON HUMAN MONOCYTES AND, AFTER IFN ACTIVATION, ...

    SBIR Phase I 1990 Department of Health and Human Services
  4. N/A

    Amount: $100,000.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  5. N/A

    Amount: $0.00

    N/A

    STTR Phase I 1999 Department of Health and Human Services
  6. N/A

    Amount: $264,820.00

    N/A

    STTR Phase II 1999 Department of Health and Human Services
  7. ANTIBODY THERAPY FOR STAPHYLOCOCUUS AUREUS INFECTIONS

    Amount: $100,000.00

    Not Available This program will develop high-power visible laser sources based on frequency conversion of 1 micron diode-pumped solid-state lasers. Improvements are needed in efficient and robust non ...

    SBIR Phase I 1999 Department of Health and Human Services
  8. Novel Immunotoxins for Depletion of Dendritic Cells

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Allogeneic stem cell transplantation (alloSCT) can be life-saving therapy for malignant and nonmalignant diseases. T cells that accompany allogeneic stem cell gra ...

    STTR Phase I 2005 Department of Health and Human Services
  9. An improved targeted vaccine strategy against anthrax

    Amount: $408,908.00

    DESCRIPTION (provided by applicant): The long term goal of this proposal is to develop a novel targeted vaccine technology against emerging infectious diseases and pathogens associated with bioterror ...

    SBIR Phase I 2005 Department of Health and Human Services
  10. REDIRECTING THE IMMUNE SYSTEM FOR ANTICANCER THERAPY

    Amount: $53,000.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government